Herbal Products Which May Affect Coagulation

(references available on request)

Although most herbs that affect coagulation have been associated with anticoagulant, antiplatelet, or fibrinolytic properties, a few herbs have coagulant properties. Specific herbal products that may potentially alter blood parameters are listed in the table below. These herbs are listed for reference; however other herbs may affect the anticoagulant response. Further investigation is needed to evaluate the effects of herbal products on warfarin therapy.

Anticoagulat and Coagulant Herbal Products
Herbal products that may affect blood coagulation
Mechanism
Type of coagulation effect
Agrimony Coagulant, human Coagulant
Alfalfa Coumarin constituents Anticoagulant
Angelica Coumarin constituents Anticoagulant
Aniseed Coumarin constituents Anticoagulant
Arnica Coumarin constituents Anticoagulant
Asafoetida

Coumarin constituents and anticoagulant in vivo

Anticoagulant
Bogbean Hemolytic activity Anticoagulant
Celery, seed or extract Coumarin constituents Anticoagulant
Cassia Inhibits platelet aggregation Anticoagulant
Chamomile, German Coumarin constituents Anticoagulant
Chamomile, Roman Coumarin constituents Anticoagulant
Chondroitin Chondroitin sulfate B (dermatan sulfate) has anticoagulant properties. Chondroitin sulfate is a component of the antithrombotic danaparoid sodium Anticoagulant
Clove Eugenol- powerful inhibitor of platelet activity Anticoagulant

Danshen

(Salvia miltiorrhiza)

Inhibition of platelet aggregation and and promotion of fibrinolytic activity

 

Anticoagulant

 

Dehydroepiandrosterone (DHEA)+

Fibrinolytic potential Anticoagulant
Dong Quai Coumarin constituents Anticoagulant
Evening Primrose Oil Ingibition of platelet aggregation by gamma-linoleic acid (GLA) Anticoagulant
Fenugreek Coumarin constituents Anticoagulant
Feverfew Inhibits platelet aggregation in vitro Anticoagulant
Fucus Anticoagulant action Anticoagulant
Garlic (Allium sativum) Decreased platelet aggregation Anticoagulant
Ginger Inhibition of platelet activity Anticoagulant
Ginkgo Inhibits platelet aggregation Anticoagulant
Ginseng, Panax Reduction of blood coagulation / decrease in INR

Anticoagulant/Coagulant

Goldenseal Heparin antagonist Coagulant
Hores-Chesnut Coumarin constituents Antocoagulant
Horseradish* Peroxidase stimulates synthesis of arachidonic acid metabolites Anticoagulant
Liquorice Inhibition of platelet activity Anticoagulant
Meadowsweet Salicylate constituents Anticoagulant
Melliot Coumarin constituents Anticoagulant
Mistletoe Lectins- agglutinating activity Coagulant
Poplar Salicylate constituents Anticoagulant
Prickly Ash, Northern Coumarin constituents Anticoagulant
Prickly Ash, Southern Coumarin constituents Anticoagulant
Quassia Coumarin constituents Anticoagluant
Red Clover Coumarin constituents Anticoagulant
Woodruff Coumarin constituents Anticoagulant
Tonka Beans Coumarin constituents Anticoagulant
Willow Salicylate constituents Anticoagluant
Yarrow Coagulant, in vivo Coagulant

* Arachidonic acid is a precursor in the biosynthesis of leukotrienes, prostaglandins and thromboxanes which influence inflammation, allergic reaction and/or platelet aggregation.

+ Although DHEA is not of plant origin, it is found in herbal sections.

Herbal Products Reported to Interact With Coumadin
Name of Herbal Product Effect On INR Bleeding Reported
Dong Quai Increase No
Danshen (Salvia miltiorrhiza) Increase No
Garlic (Allium sativum) (high dose) Increase Yes, but not in patients on warfarin
Ginkgo (Ginkgo biloba) Increase Yes
Ginseng Decrease No

Above interaction data obtained from case reports of adverse events.

 

Herbal Products With Unknown Effects On Coagulation and Coumadin
Herbal Product
Echinacea (Echinacea spp.)
Glucosamine
Saw palmetto (Serenoa repens)
St. John's wort
Valerian (Valeriana officinalis)

Based on a review of literature, no information was located about an effect of these herbs on coagulation. In addition, no studies evaluating the potential for these herbs to interact with warfarin were located. Their use in combination with Coumadin should therefore be approached with caution.

Numerous factors, alone or in combination, including travel. changes in diet, environment, physical state and medication may influence response of the patient to anticoagulants. It is generally good practice to monitor the patient's response with additional prothrombin time (PT)/International Normalized Ratio (INR) determinations in the period immediately after discharge from the hospital, and whenever other medications are initiated, discontinued or taken irregularly. Medications of unknown interactions with coumarins are best regarded with caution. When these medications are started or stopped, more frequent PT/INR monitoring is advisable.